John C.K. Milligan, IV
2019
Compensation breakdown
Non-Equity Incentive Plan | $315,000 |
---|---|
Option Awards | $645,956 |
Salary | $450,000 |
Other | $29,683 |
Total | $1,440,639 |
Milligan received $646K in option awards, accounting for 45% of the total pay in 2019.
Milligan also received $315K in non-equity incentive plan, $450K in salary and $29.7K in other compensation.
Rankings
In 2019, John C.K. Milligan, IV's compensation ranked 7,505th out of 13,971 executives tracked by ExecPay. In other words, Milligan earned more than 46.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,505 out of 13,971 | 46th |
Division Manufacturing | 2,909 out of 5,701 | 49th |
Major group Chemicals And Allied Products | 1,094 out of 2,200 | 50th |
Industry group Drugs | 931 out of 1,886 | 51st |
Industry Pharmaceutical Preparations | 688 out of 1,398 | 51st |
Pay ratio
John C.K. Milligan, IV's Pay | $1,440,639 |
---|---|
Median Employee's Pay | $114,000 |
Pay Ratio | 13to 1 |
In 2019, the annual total compensation of John C.K. Milligan, IV was $1,440,639.
The annual total compensation of the median employee at TherapeuticsMD was $114,000.
The ratio of John C.K. Milligan, IV's pay to the pay of median employee was therefore 13 to one.
Milligan's colleagues
We found four more compensation records of executives who worked with John C.K. Milligan, IV at TherapeuticsMD in 2019.